Yield10 Bioscience, Inc. (YTEN) Misses Q4 EPS by 9c

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q4 EPS of ($0.79), $0.09 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $195 thousand versus the consensus estimate of $240 thousand.

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c